Targeting the NAD⁺ salvage pathway: roles of NAMPT in the tumor microenvironment

Nicotinamide adenine dinucleotide (NAD⁺) is a central redox cofactor that supports cellular metabolism, redox balance and signal transduction. Nicotinamide phosphoribosyltransferase (NAMPT) catalyzes the rate-limiting step of NAD⁺ salvage pathway in both malignant and non-malignant cells of the tumor microenvironment (TME). Whilst direct restriction of NAD⁺ metabolism in cancer cells has yielded limited clinical benefit, emerging evidence reveals that NAMPT shapes antitumor immunity by reprogramming immune cell function and the metabolic landscape of the TME. Parallel advances in medicinal chemistry, including bifunctional inhibitors, drug-delivery systems and proteolysis-targeting chimeras (PROTACs) are enabling more selective NAMPT-targeted agents. This review examines the context-dependent roles of NAMPT across immune and stromal compartments of the TME and evaluates emerging therapeutic approaches, highlighting their potential to overcome current limitations and advance NAMPT-targeted immunotherapy.

Authors

Institutions

Publication Details

Journal
Carcinogenesis
Published
2026-11-13
DOI
https://doi.org/10.1093/carcin/bgag083
Primary Topic
Sirtuins and Resveratrol in Medicine
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Targeting the NAD⁺ salvage pathway: roles of NAMPT in the tumor microenvironment

Guiquan Zhu, Shengqi Zhao, Wanrong Meng, Jinghang Wei
Carcinogenesis
Sirtuins and Resveratrol in Medicine
article

Targeting the NAD⁺ salvage pathway: roles of NAMPT in the tumor microenvironment

Guiquan Zhu, Shengqi Zhao, Wanrong Meng, Jinghang Wei
article en

Abstract

Nicotinamide adenine dinucleotide (NAD⁺) is a central redox cofactor that supports cellular metabolism, redox balance and signal transduction. Nicotinamide phosphoribosyltransferase (NAMPT) catalyzes the rate-limiting step of NAD⁺ salvage pathway in both malignant and non-malignant cells of the tumor microenvironment (TME). Whilst direct restriction of NAD⁺ metabolism in cancer cells has yielded limited clinical benefit, emerging evidence reveals that NAMPT shapes antitumor immunity by reprogramming immune cell function and the metabolic landscape of the TME. Parallel advances in medicinal chemistry, including bifunctional inhibitors, drug-delivery systems and proteolysis-targeting chimeras (PROTACs) are enabling more selective NAMPT-targeted agents. This review examines the context-dependent roles of NAMPT across immune and stromal compartments of the TME and evaluates emerging therapeutic approaches, highlighting their potential to overcome current limitations and advance NAMPT-targeted immunotherapy.

Carcinogenesis
Sichuan University (CN), State Key Laboratory of Oral Diseases (CN)
Sirtuins and Resveratrol in Medicine
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon